#fda regulation

1 story

#compounding pharmacies #drug safety #eli lilly #glp-1 drugs #news #pharmaceutical pricing #telehealth #tirzepatide #weight-loss medications #world

The risky boom in cut-price weight-loss drugs
Compounding pharmacies are flooding the market with cheaper versions of GLP-1 drugs, but with far less oversight than brand-name alternatives.
TIME · 3m